Chordoma clinical trials

Explore recruiting chordoma clinical trials.

Recruiting chordoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chordoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

REGOBONE_A Randomized Phase II, placebo-controlled, multicenter study evaluating efficacy and safety of regorafenib in patients with metastatic bone sarcomas

France

Therapeutic exploratory (Phase II) EU CTIS Study details

REGOSTA – A multicentre exploratory phase II study describing the efficacy and safety of regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chordoma trials by city

Chordoma in Toronto Chordoma in Vancouver Chordoma in Montreal Chordoma in Calgary Chordoma in Edmonton Chordoma in Ottawa Chordoma in Winnipeg Chordoma in Quebec City Chordoma in Hamilton Chordoma in Kitchener Chordoma in London Chordoma in Halifax Chordoma in New York Chordoma in Los Angeles Chordoma in Chicago Chordoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease